Costimulation Blockade and Tolerance in Solid Organ Transplantation CME

Author Information and Disclosures

Release Date: July 11, 2008; Valid for credit through July 11, 2009

Credits Available
Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
BMS
Learning Objectives
Upon completion of this activity, participants will be able to:
  1. Summarize the biology and evolution of costimulation blockade as a potential strategy for solid organ transplantation
  2. State the most important lessons learned from experimental and preclinical studies of costimulation blockade and tolerance in transplantation
Authors and Disclosures

Flavio Vincenti, MD
Disclosure: Flavio Vincenti, MD, has disclosed that he has received grants from Roche Wyeth, Novartis, Bristol-Myers Squibb, Genentech, Iconix, and Genzyme.


Christian P. Larsen, MD, PhD
Disclosure: Christian P. Larsen, MD, PhD, has disclosed no relevant financial relationships.


Mohammed H. Sayegh, MD
Disclosure: Mohammed H. Sayegh, MD, has disclosed that he has served as a consultant for Genzyme.


Susan Smith, MN, PhD
Disclosure: Susan Smith, MN, PhD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.